XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Treasury Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144   $ 38,560,117 $ (45,222,302) $ 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278        
Provision for compensation expense related to stock-based compensation   305,229 305,229
Exercise of stock options into common stock $ 17   137,040 137,057
Exercise of stock options into common stock (in Shares) 162,956        
Net income (Loss)   (2,380,935) (2,380,935)
Balance at Mar. 31, 2022 $ 851,660 $ 21,952,000 $ 2,161   39,002,386 (47,603,237) 14,204,970
Balance (in Shares) at Mar. 31, 2022 170,332 21,952 21,605,234        
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144   38,560,117 (45,222,302) 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278        
Net income (Loss)             5,727,852
Balance at Sep. 30, 2022 $ 851,660 $ 21,952,000 $ 2,176   39,771,593 (39,494,450) 23,082,979
Balance (in Shares) at Sep. 30, 2022 170,332 21,952 21,750,804        
Balance at Mar. 31, 2022 $ 851,660 $ 21,952,000 $ 2,161   39,002,386 (47,603,237) 14,204,970
Balance (in Shares) at Mar. 31, 2022 170,332 21,952 21,605,234        
Provision for compensation expense related to stock-based compensation   257,476 257,476
Net income (Loss)   14,389,221 14,389,221
Balance at Jun. 30, 2022 $ 851,660 $ 21,952,000 $ 2,161   39,259,862 (33,214,016) 28,851,667
Balance (in Shares) at Jun. 30, 2022 170,332 21,952 21,605,234        
Provision for compensation expense related to stock-based compensation   387,298 387,298
Exercise of stock options into common stock $ 15   124,433 124,448
Exercise of stock options into common stock (in Shares) 145,570        
Net income (Loss)     (6,280,434) (6,280,434)
Balance at Sep. 30, 2022 $ 851,660 $ 21,952,000 $ 2,176   39,771,593 (39,494,450) 23,082,979
Balance (in Shares) at Sep. 30, 2022 170,332 21,952 21,750,804        
Balance at Dec. 31, 2022 $ 851,660 $ 21,952,000 $ 2,176 39,819,420 (31,590,583) 31,034,673
Balance (in Shares) at Dec. 31, 2022 170,332 21,952 21,750,804      
Provision for compensation expense related to stock-based compensation 420,748 420,748
Exercise of stock options into common stock 1,185 1,185
Exercise of stock options into common stock (in Shares) 1,500        
Net income (Loss) (230,215) (230,215)
Balance at Mar. 31, 2023 $ 851,660 $ 21,952,000 $ 2,176 40,241,353 (31,820,798) 31,226,391
Balance (in Shares) at Mar. 31, 2023 170,332 21,952 21,752,304      
Balance at Dec. 31, 2022 $ 851,660 $ 21,952,000 $ 2,176 39,819,420 (31,590,583) 31,034,673
Balance (in Shares) at Dec. 31, 2022 170,332 21,952 21,750,804      
Net income (Loss)             (4,587,769)
Balance at Sep. 30, 2023 $ 851,660 $ 21,952,000 $ 2,176 $ (100,225) 42,074,553 (36,178,352) 28,601,812
Balance (in Shares) at Sep. 30, 2023 170,332 21,952 21,752,304 (100,775)      
Balance at Mar. 31, 2023 $ 851,660 $ 21,952,000 $ 2,176 40,241,353 (31,820,798) 31,226,391
Balance (in Shares) at Mar. 31, 2023 170,332 21,952 21,752,304      
Provision for compensation expense related to stock-based compensation 443,800 443,800
Extension of warrants 917,581   917,581
Net income (Loss) (5,297,655) (5,297,655)
Balance at Jun. 30, 2023 $ 851,660 $ 21,952,000 $ 2,176 41,602,734 (37,118,453) 27,290,117
Balance (in Shares) at Jun. 30, 2023 170,332 21,952 21,752,304      
Provision for compensation expense related to stock-based compensation 471,819 471,819
Purchases of treasury stock $ (100,225) (100,225)
Purchases of treasury stock (in Shares) (100,775)      
Net income (Loss) 940,101 940,101
Balance at Sep. 30, 2023 $ 851,660 $ 21,952,000 $ 2,176 $ (100,225) $ 42,074,553 $ (36,178,352) $ 28,601,812
Balance (in Shares) at Sep. 30, 2023 170,332 21,952 21,752,304 (100,775)